In conclusion, we identify a SNHG17/LRPPRC/c-Myc regulatory axis and characterize its function in G1/S transition, which uncovers new mechanisms underlying cell proliferation and tumor growth, and provides potential targets for anti-cancer therapy. Here, SNHG17 is linked to cancer.